Eugene Myron Holuka

Filings by Eugene Myron Holuka span 2 companies, the busiest being Citius Oncology, Inc. and Citius Pharmaceuticals, Inc. Between 13 March 2024 and 19 September 2025, the trades on record add up to 5 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 22 December 2025: a share grant, in Citius Oncology, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.